Wasim Malik
Consultant / Advisor at HONEYWELL INTERNATIONAL INC.
Profile
As the Managing Partner, Wasim oversees the overall strategy, investments and partnerships at Iaso Ventures.
He previously served as the first Chief Digital Strategist at Roivant Sciences, a global biopharma company ($7.3B IPO).
There he led digital health investments, strategy and partnerships to help accelerate drug development and commercialization across 15+ therapeutic areas, and contributed to incubation and early growth of various portfolio companies.
As part of his work in the healthcare provider industry, Wasim has served on the faculty at Massachusetts General Hospital, the flagship teaching hospital of Harvard Medical School, for over a decade.
Affiliated with the MGH Department of Psychiatry and the Clinical Trials Network and Institute, he built a research program on tech-enabled clinical research in neurology, psychiatry and anesthesiology, with a focus on neurodegenerative and movement disorder biomarkers, and brain-computer interfaces.
He has also taught entrepreneurship, neuroscience and machine learning at MIT, most recently as faculty on the NIH-supported IMPACT Program, and is affiliated with the MIT Department of Brain & Cognitive Sciences.
He currently sits on the board of directors at The Epilepsy Foundation, Scaffold Therapeutics, Altimate Health, ClexBio and BioTrak Health, with previous board roles at Saphetor and monARC Bionetworks.
He serves as a Senior Advisor for Life Sciences at Health Catalyst .
He is a startup mentor at NYU Stern’s Endless Frontier Labs, the neuro stream at the Creative Destruction Lab, and the health-tech stream at Dreamit Ventures.
He is an angel investor at Sky Ventures, MIT Alumni Angels, and HBS Angels of Boston.
Wasim received his DPhil in electrical engineering from Oxford, postdoctoral training in neuroscience from MIT, and finance education in venture capital and private equity from Harvard Business School.
Wasim Malik active positions
| Companies | Position | Start |
|---|---|---|
| HONEYWELL INTERNATIONAL INC. | Consultant / Advisor | 2022-07-31 |
Iaso Ventures
 Iaso Ventures Investment ManagersFinance Iaso Ventures Management Firm LLC (Iaso Ventures) is a venture capital firm formed in 2019. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 2019-12-31 |
Celéri Health, Inc.
 Celéri Health, Inc. Internet Software/ServicesTechnology Services Celeri Health, Inc. provides a reimbursable, caregiver-centric, patient-reported outcomes data capture system. Its solution helps clinicians to determine the right therapy for the right person at the right time. The company was founded by Michael Fishman and Jason Pope in 2018 and is headquartered in Paoli, PA. | Consultant / Advisor | 2021-12-31 |
| BioTrak Health, Inc. | Consultant / Advisor | - |
Zafrens, Inc.
 Zafrens, Inc. BiotechnologyHealth Technology Zafrens, Inc. is an American company that is pioneering an ultra-high throughput platform to isolate, culture, image, and sequence millions of cells per day. Zafrens is based in California. The proprietary platform allows for full characterization of diverse cell populations, as well as directly correlating molecular profiles (DNA, RNA, protein) to cell phenotype and function. The company's mission is to unlock the full story of every cell to accelerate drug discovery. The CEO of the company is Kandaswamy Vijayan. | Consultant / Advisor | 2022-12-31 |
Mass General Brigham, Inc.
 Mass General Brigham, Inc. Medical/Nursing ServicesHealth Services Mass General Brigham, Inc. engages in the provision of patient care, research, teaching, and community services. It offers community and specialty hospitals, physician network, community health centers, and home care. The firm also sponsors research programs and community health outreach programs. The company was founded in 1994 and is headquartered in Boston, MA. | Director/Board Member | 2007-12-31 |
Altimate Health Corp.
 Altimate Health Corp. Hospital/Nursing ManagementHealth Services Altimate Health Corp. provides psychiatric treatment services. | Director/Board Member | 2019-12-31 |
Nordovo Biosciences AS
 Nordovo Biosciences AS BiotechnologyHealth Technology Nordovo Biosciences AS, operating under the name clexbio, is a pre-clinical stage biotech company based in Oslo, Norway. The Norwegian company is focused on developing next-generation tissue-engineered allogeneic grafts for transplant, using its proprietary platform technologies clex and vivoset. clexbio combines advanced bio-fabrication approaches with its proprietary hydrogel technology clex to create breakthrough solutions for tissue engineering and single-cell techniques. The private company was founded by Manuel Schweikle and Armend G. Håti, with Armend G. Håti serving as CEO since incorporation. | Independent Dir/Board Member | 2021-12-31 |
| Scaffold Therapeutics, Inc. | Director/Board Member | 2021-12-31 |
| ░░░░░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Former positions of Wasim Malik
| Companies | Position | End |
|---|---|---|
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Wasim Malik
| University of Oxford | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| HONEYWELL INTERNATIONAL INC. | Electronic Technology |
| HEALTH CATALYST, INC. | Technology Services |
| Private companies | 14 |
|---|---|
Mass General Brigham, Inc.
Mass General Brigham, Inc. Medical/Nursing ServicesHealth Services Mass General Brigham, Inc. engages in the provision of patient care, research, teaching, and community services. It offers community and specialty hospitals, physician network, community health centers, and home care. The firm also sponsors research programs and community health outreach programs. The company was founded in 1994 and is headquartered in Boston, MA. | Health Services |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Health Technology |
| Epilepsy Therapy Project | |
Myolex, Inc.
 Myolex, Inc. Miscellaneous Commercial ServicesCommercial Services Myolex, Inc. fitness tracker provider. It develops hardware and software to accurately measure total body composition, as well as the fat content and muscle quality for specific body parts. The company was founded in 2009 by Seward Rutkove and Jose Bohorquez and is headquartered in San Francisco, CA. | Commercial Services |
Saphetor SA
 Saphetor SA Packaged SoftwareTechnology Services Saphetor SA develops software and analytical processes using proprietary algorithms and trade secret know-how to identify genetic variants. Its services include data-driven solutions, accurate diagnoses, and informed decisions for the selection of the best therapies, especially for cancer and difficult to diagnose conditions, such as rare diseases or cognitive impairment. The company was founded by Andreas Massouras in 2014 and is headquartered in Lausanne, Switzerland. | Technology Services |
monARC Bionetworks, Inc.
 monARC Bionetworks, Inc. Packaged SoftwareTechnology Services monARC Bionetworks, Inc. operates as a healthcare technology company. The firm manages the data of the patients to therapy development models into integrated and collaborative endeavors with patients at the center. The company was founded by Komathi Stem and is headquartered in San Francisco, CA. | Technology Services |
Celéri Health, Inc.
Celéri Health, Inc. Internet Software/ServicesTechnology Services Celeri Health, Inc. provides a reimbursable, caregiver-centric, patient-reported outcomes data capture system. Its solution helps clinicians to determine the right therapy for the right person at the right time. The company was founded by Michael Fishman and Jason Pope in 2018 and is headquartered in Paoli, PA. | Technology Services |
Pragma Biosciences, Inc.
 Pragma Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Pragma Biosciences, Inc. is a drug discovery company that mines the microbiome for potential drug candidates. The company is headquartered in San Carlos, CA. | Commercial Services |
Altimate Health Corp.
Altimate Health Corp. Hospital/Nursing ManagementHealth Services Altimate Health Corp. provides psychiatric treatment services. | Health Services |
Iaso Ventures
Iaso Ventures Investment ManagersFinance Iaso Ventures Management Firm LLC (Iaso Ventures) is a venture capital firm formed in 2019. The firm is headquartered in Boston, Massachusetts. | Finance |
| BioTrak Health, Inc. | |
Nordovo Biosciences AS
Nordovo Biosciences AS BiotechnologyHealth Technology Nordovo Biosciences AS, operating under the name clexbio, is a pre-clinical stage biotech company based in Oslo, Norway. The Norwegian company is focused on developing next-generation tissue-engineered allogeneic grafts for transplant, using its proprietary platform technologies clex and vivoset. clexbio combines advanced bio-fabrication approaches with its proprietary hydrogel technology clex to create breakthrough solutions for tissue engineering and single-cell techniques. The private company was founded by Manuel Schweikle and Armend G. Håti, with Armend G. Håti serving as CEO since incorporation. | Health Technology |
Zafrens, Inc.
Zafrens, Inc. BiotechnologyHealth Technology Zafrens, Inc. is an American company that is pioneering an ultra-high throughput platform to isolate, culture, image, and sequence millions of cells per day. Zafrens is based in California. The proprietary platform allows for full characterization of diverse cell populations, as well as directly correlating molecular profiles (DNA, RNA, protein) to cell phenotype and function. The company's mission is to unlock the full story of every cell to accelerate drug discovery. The CEO of the company is Kandaswamy Vijayan. | Health Technology |
| Scaffold Therapeutics, Inc. |
- Stock Market
- Insiders
- Wasim Malik